BACKGROUND Our study aimed to echocardiographically evaluate myocardial adaption and outcome after transfemoral aortic valve implantation (TAVI TF) for severe aortic stenosis based on LVEF.
RESULTS Aortic valve orifice and mean gradient significantly improved after TAVI in the whole collective in contrast to LV dimensions and LVEF, which largely remained unchanged (LV enddiastolic diameter: from 52.5 AE 9.4 to 52.7 AE 8.6 mm; p¼0.59, LVEF from 45.5 AE 10% to 47.8 AE 13.9%, p¼0.13). However, pts. with reduced baseline LVEF significantly improved, while those with preserved LVEF remained stable or slightly deteriorated ( RESULTS There were significant differences with regard to major comorbidities which were more frequent in patients aged 75 years compared to patients >75 years: history of cancer (22% vs 12%, p<0.001), previous coronary artery bypass grafting (30% vs 11%, p<0.001), and renal insufficiency requiring hemodialysis (11% vs 1%, p¼0.007). With regard to echocardiography findings, ejection fraction was significantly lower in patients aged 75 years compared to patients >75 years (50.2% vs 54.4%, p¼0.016). With regard to outcomes, there were no significant differences in the procedural success rate (92% vs 92%, p¼0.908), 30-day mortality (10% vs 11%, p¼0.747) and 30-day combined safety endpoint (21% vs 22%, p¼0.802) between the 2 groups. However, regarding mid-term outcome, the survival rate of patients aged 75 years was significantly higher in comparison with patients aged >75 years (log-rank p¼0.037). The COX regression model showed IDDM, life-threatening bleeding and creatinine clearance (<60 ml/min) as the independent predictors of mid-term cumulative mortality among younger patients.
CONCLUSIONS Although patients aged 75 years have more comorbidities compared to patients aged >75 years, TAVI can be effectively and safely performed. Furthermore, mid-term outcome seems to be better among the patients 75 years compared to patients aged >75 years. METHODS 6249 pt undergoing tv-TAVR in 2011 and 2012 were included in this ongoing non-randomized national multicenter registry. In-hospital mortality or 30-days mortality (30dm) was chosen as a binary outcome measure. First, 34 potential risk factors were tested in an univariate manner by Fisher's exact test for significant influence on mortality and multiple logistic regression with backward and forward selection. Calibration was ascertained by the Hosmer-Lemeshow 
